MediciNova
MNOV
MNOV
32 hedge funds and large institutions have $19M invested in MediciNova in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-10
Holders Change %
-23.81%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
9
Reduced
12
Closed
12
Calls
$184K
Puts
–
Net Calls
+$184K
Net Calls Change
-$54K
Top Buyers
| 1 |
B
Bailard
Foster City,
California
|
+$75K |
| 2 |
Barclays
London,
United Kingdom
|
+$31.5K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$31K |
| 4 |
State Street
Boston,
Massachusetts
|
+$25.2K |
| 5 |
Renaissance Technologies
New York
|
+$19.8K |
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$352K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$295K |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$144K |
| 4 |
HF
HRT Financial
New York
|
-$115K |
| 5 |
Goldman Sachs
New York
|
-$90K |
